NCT07512856 The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)
| NCT ID | NCT07512856 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute of HIV Research and Innovation Foundation, Thailand |
| Condition | HIV Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2024-02-01 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.
Eligibility Criteria
Inclusion Criteria: * Self-identified transgender women, transgender men, or non-binary persons * Age ≥18 years * HIV-negative * Engaged in chemsex or substance use within past 12 months * Able to provide informed consent Exclusion Criteria: • Inability to communicate in Thai sufficiently to complete study procedures
Contact & Investigator
Nittaya Phanuphak, MD,PhD.
PRINCIPAL INVESTIGATOR
Institute of HIV Research and Innovation (IHRI)
Frequently Asked Questions
Who can join the NCT07512856 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07512856 currently recruiting?
Yes, NCT07512856 is actively recruiting participants. Contact the research team at nittaya.p@ihri.org for enrollment information.
Where is the NCT07512856 trial being conducted?
This trial is being conducted at Pathum Wan, Thailand.
Who is sponsoring the NCT07512856 clinical trial?
NCT07512856 is sponsored by Institute of HIV Research and Innovation Foundation, Thailand. The principal investigator is Nittaya Phanuphak, MD,PhD. at Institute of HIV Research and Innovation (IHRI). The trial plans to enroll 140 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.